Prognostic value of RGS1 and mTOR Immunohistochemical expression in Egyptian multiple myeloma patients; A single center study.

PLoS One · 2023 · PMC10337974 · PMID 37437037

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

showed a trendp = 0.08so close (0.05 < p ≤ 0.1)

studied the mTOR marker among the diffuse large B cell lymphoma patients and revealed that the high mTOR expression showed a trend toward advanced clinical stage than others (78% vs. 54%, p = 0.08) [ 46 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.